World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
42141
World Ranking
10313
National Ranking
994

Henry C Kitchener publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Henry C Kitchener sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 404 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Henry C Kitchener D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Henry C Kitchener sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Henry C Kitchener is affiliated with the University of Manchester in the United Kingdom. Their research is primarily situated within the field of Medicine, with a focus on several subfields including Epidemiology, Surgery, Obstetrics and Gynecology, Oncology, and Reproductive Medicine.

The scientist's work covers a range of topics mainly related to cancer treatments and screening, particularly concerning endometrial and cervical cancers. The main topics of their scientific output include:

  • Endometrial and Cervical Cancer Treatments
  • Cervical Cancer and HPV Research
  • Genital Health and Disease
  • Ovarian cancer diagnosis and treatment
  • Global Cancer Incidence and Screening
  • Management of metastatic bone disease
  • Genetic factors in colorectal cancer

Key recent publications by Henry C Kitchener reflect this focus and include:

  • "Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy", 2020, Journal of Clinical Oncology
  • "Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data", 2022, BMJ
  • "Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial", 2020, International Journal of Radiation Oncology*Biology*Physics
  • "The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot", 2022, British Journal of Cancer
  • "Age-specific outcomes from the first round of HPV screening in unvaccinated women: Observational study from the English cervical screening pilot", 2021, BJOG An International Journal of Obstetrics & Gynaecology

The scientist has collaborated frequently with other researchers, including Stephanie M. de Boer, Remi A. Nout, Linda Mileshkin, Hans W. Nijman, and Anthony Fyles.

Henry C Kitchener's work has been published repeatedly in several specialized journals and venues such as:

  • Obstetrical & Gynecological Survey
  • International Journal of Radiation Oncology*Biology*Physics
  • BJOG An International Journal of Obstetrics & Gynaecology
  • International Journal of Cancer
  • Radiotherapy and Oncology

Among recognitions, the scientist has been awarded Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

    J. Paavonen;P. Naud;J. Salmeron;C. M. Wheeler

  • Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

    H Kitchener;A M C Swart;Q Qian

  • Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

    Guglielmo Ronco;Joakim Dillner;K Miriam Elfström;Sara Tunesi

  • Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

    Jorma Paavonen;David Jenkins;F. Xavier Bosch;Paulo Naud

  • Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

    Sean Kehoe;Jane Hook;Matthew Nankivell;Gordon C Jayson

  • Cervical Cancer: A Global Health Crisis

    William Small;Monica A. Bacon;Amishi Bajaj;Linus T. Chuang

  • Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    Matti Lehtinen;Jorma Paavonen;Cosette M. Wheeler;Unnop Jaisamrarn

  • Human papillomavirus and cervical cancer.

    Emma J Crosbie;Mark H Einstein;Silvia Franceschi;Henry C Kitchener

  • Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis.

    Astec;P Blake;Ann Marie Swart

  • Management of women who test positive for high-risk types of human papillomavirus: The HART study

    Jack Cuzick;A Szarewski;H Cubie;G Hulman

  • Comprehensive control of human papillomavirus infections and related diseases.

    F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki

  • Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    Cosette M. Wheeler;Xavier Castellsagué;Suzanne M. Garland;Anne Szarewski

  • 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

    A du Bois;M Quinn;T Thigpen;J Vermorken

  • Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

    Stephanie M. de Boer;Melanie E. Powell;Linda Mileshkin;Dionyssios Katsaros

  • Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

    Alicia León-Castillo;Stephanie M. de Boer;Melanie E. Powell;Linda R. Mileshkin

  • 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer Report From the Fourth Ovarian Cancer Consensus Conference

    Gavin C.E. Stuart;Henry Kitchener;Monica Bacon;Andreas duBois

  • HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial

    Henry C Kitchener;Maribel Almonte;Claire Thomson;Paula Wheeler

  • Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.

    Ellen Stelloo;Tjalling Bosse;Remi A Nout;Helen J MacKay

  • Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

    Stephanie M de Boer;Melanie E Powell;Linda Mileshkin;Dionyssios Katsaros

  • Future acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudes

    Loretta Brabin;Stephen A. Roberts;Farah Farzaneh;Henry C. Kitchener

Frequent Co-Authors

Chris Roberts
Chris Roberts University of Manchester
Julian Peto
Julian Peto London School of Hygiene & Tropical Medicine
Peter L. Stern
Peter L. Stern University of Manchester
Hans W. Nijman
Hans W. Nijman University Medical Center Groningen
Carien L. Creutzberg
Carien L. Creutzberg Leiden University Medical Center
Suzanne M. Garland
Suzanne M. Garland University of Melbourne
Stephen A Roberts
Stephen A Roberts University of Manchester
Xavier Castellsagué
Xavier Castellsagué University of Barcelona
Jorma Paavonen
Jorma Paavonen University of Helsinki
Gary Dubin
Gary Dubin GlaxoSmithKline (United Kingdom)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future in healthcare? The USA offers a range of online degrees that prepare students for diverse roles in medicine and allied fields. These pathways give flexibility for working professionals and career changers, letting you advance your education remotely.

If you’re interested in nutrition and wellness, pursuing the best online food science degree can lead to careers in dietetics, food technology, or public health. For those looking to move into healthcare administration, online mha programs cahme accredited offer reputable options to build leadership and management skills in hospital settings.

Nurses can further their careers by exploring rn to bsn online without clinicals degrees, which allow them to earn their Bachelor of Science in Nursing without on-site requirements—ideal for busy schedules. Advanced practice nurses might opt for dnp programs online to achieve the highest level of clinical nursing expertise in a streamlined format.

By exploring these related online programs, you can discover new ways to expand your qualifications and shape your career in the ever-evolving field of medicine.

Best Scientists Citing Henry C Kitchener

Trending Scientists

Recently Published Articles